Real world safety outcomes using cemiplimab for cutaneous squamous cell carcinomaJulie Valentin, Anne Pham‐Ledard, E. Gérard et al.|Journal of Geriatric Oncology|2021Cited by 32
Real-World Survival in Patients with Metastatic Melanoma after Discontinuation of Anti-PD-1 Immunotherapy for Objective Response or Adverse Effects: A Retrospective StudyJulie Valentin, E. Gérard, M. Beylot‐Barry et al.|Journal of Oncology|2021Cited by 21